Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jan 5;11(1):e039358.
doi: 10.1136/bmjopen-2020-039358.

Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis

Suhairul Sazali  1 , Salziyan Badrin  2 , Mohd Noor Norhayati  1 , Nur Suhaila Idris  1
Affiliations
Meta-Analysis

Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis

Suhairul Sazali et al. BMJ Open. .

Abstract

Objective: To determine the effects of coenzyme Q10 (CoQ10) for reduction in the severity, frequency of migraine attacks and duration of headache in adult patients with migraine.

Design: Systematic review and meta-analysis.

Data sources: Cochrane Central Register of Controlled Trials, CENTRAL, MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Psychological Information Database (PsycINFO) from inception till December 2019.

Study selection: All randomised control trials comparing CoQ10 with placebo or used as an adjunct treatment included in this meta-analysis. Cross-over designs and controlled clinical trials were excluded.

Data synthesis: Heterogeneity at face value by comparing populations, settings, interventions and outcomes were measured and statistical heterogeneity was assessed by means of the I2 statistic. The treatment effect for dichotomous outcomes were using risk ratios and risk difference, and for continuous outcomes, mean differences (MDs) or standardised mean difference; both with 95% CIs were used. Subgroup analyses were carried out for dosage of CoQ10 and if CoQ10 combined with another supplementation. Sensitivity analysis was used to investigate the impact risk of bias for sequence generation and allocation concealment of included studies.

Results: Six studies with a total of 371 participants were included in the meta-analysis. There is no statistically significant reduction in severity of migraine headache with CoQ10 supplementation. CoQ10 supplementation reduced the duration of headache attacks compared with the control group (MD: -0.19; 95% CI: -0.27 to -0.11; random effects; I2 statistic=0%; p<0.00001). CoQ10 usage reduced the frequency of migraine headache compared with the control group (MD: -1.52; 95% CI: -2.40 to -0.65; random effects; I2 statistic=0%; p<0.001).

Conclusion: CoQ10 appears to have beneficial effects in reducing duration and frequency of migraine attack.

Prospero registration number: CRD42019126127.

Keywords: complementary medicine; migraine; neurology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Lipton RB, Stewart WF, Diamond S, et al. . Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache 2001;41:646–57. 10.1046/j.1526-4610.2001.041007646.x - DOI - PubMed
    1. Steiner TJ, Stovner LJ, Vos T, et al. . Migraine is first cause of disability in under 50S: will health politicians now take notice? J Headache Pain 2018;19:17. 10.1186/s10194-018-0846-2 - DOI - PMC - PubMed
    1. Hershey AD, Powers SW, Vockell A-LB, et al. . Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007;47:73–80. 10.1111/j.1526-4610.2007.00652.x - DOI - PubMed
    1. Ashina M, Tvedskov JF, Lipka K, et al. . Matrix metalloproteinases during and outside of migraine attacks without aura. Cephalalgia 2010;30:303–10. 10.1111/j.1468-2982.2009.01954.x - DOI - PubMed
    1. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. . Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004;113:1447–55. 10.1172/JCI200421227 - DOI - PMC - PubMed